USE OF GLP-1 RECEPTOR AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
摘要
<p>The present invention describes the methods of using incretin mimetics such as GLP-1 receptor agonists, particularly exenatide, to treat short bowel syndrome and spastic or hyperactive esophageal motor disorders.</p>
申请公布号
WO2008134425(A1)
申请公布日期
2008.11.06
申请号
WO2008US61417
申请日期
2008.04.24
申请人
CEDARS-SINAI MEDICAL CENTER;PIMENTEL, MARK;SOFFER, EDY, E.;CONKLIN, JEFFREY
